Recent Developments in Drug-Coated Balloons – Part 4
Peripheral Drug-eluting Balloon Earn FDA Breakthrough Device Designation In addition to the three coronary DCB breakthrough devices mentioned above, two peripheral DCBs also gained breakthrough status in the past year. Orchestra BioMed, in partnership with Terumo, in September 2019 announced breakthrough device designation for the Virtue Sirolimus-Eluting Balloon (SEB) in the treatment of below-the-knee (BTK) peripheral artery disease. The Virtue SEB is a novel, first-in-class drug/device combination product that delivers [...]

